Dentons has advised Chinese financial firm JD Group on the sale of its insurance business, FTLife Insurance Company Limited, for $2.74 billion (HK$21.5 billion approximately) to NWS Holdings Limited which was counselled by Sullivan & Cromwell.

According to Reuters, this sale by JD Group is be one of the top five insurance M&A deals ever to take place in Hong Kong.

JD Group previously acquired FTLife from Ageas, a Brussels-based insurance firm, for $1.4 billion back in 2016. Reuters added that JD Group, which has brokerage, trust, mutual funds and private equity businesses, was once the most valuable company on the Chinese National Equities Exchange and Quotations, the country’s most active over-the-counter equity exchange.

The Dentons team was led by partners Gordon Ng, Li Shoushuang and Emilia Shi.

 

大成、美国苏利文助力九鼎集团215亿港元出售富通保险

香港新创建集团以215亿港元(约合27.4亿美元)从九鼎集团手中收购富通保险。此次交易中,大成律师事务所为九鼎集团 提供法律服务,美国苏利文▪克伦威尔律师事务所为香港新创建集团提供法律服务。

据路透社报道,此项交易将成为香港有史以来最大的五笔保险业并购交易之一。

2016年,九鼎集团从比利时最大的保险集团富杰保险公司手里以14亿美元的价格收购了富通保险。据路透社报道,九鼎集团涵盖经纪业务、信托业务、共同基金业务、私募股权业务,曾是中国全国中小企业股份转让系统中市值最高的公司。

大成团队由合伙人Gordon Ng、李寿双、Emilia Shi主导。

 

To contact the editorial team, please email ALBEditor@thomsonreuters.com.

Related Articles

Weil, Wong & Partners guide $2.6 bln Malaysia airport deal

by Nimitt Dixit |

U.S law firm Weil, Gotshal & Manges and Wong & Partners, Baker McKenzie’s Malaysia member firm, have guided investment firm Global Infrastructure Partners (GIP) and a consortium led by Khazanah Nasional Bhd, respectively, on a $2.6 billion take-private offer for Malaysia Airports Holdings (MAH).

Nishimura continues SEA growth with energy partner

by Nimitt Dixit |

Japanese Big Six law firm Nishimura & Asahi has continued the planned expansion of its Southeast Asia offerings with the addition of energy-focused finance and M&A partner Sean Conaty.

GT, Goodwin act as Japan's Ono buys U.S. drugmaker for $2.4 bln

Greenberg Traurig has represented Japan’s Ono Pharmaceutical Co on its $2.4 billion acquisition of  U.S.-based cancer drugmaker Deciphera, which was advised by Goodwin Procter.